Entity coverage

Ligand Pharmaceuticals Incorporated

LGND · 8 events mapped

Market Ontology has mapped 8 distinct macro, policy, and market events to LGND. Each entry below traces the causal channel from the driver to the assumption it moved.

Recent event impacts

Full ledger →
  • 2026-07-14EventAcquisition of royalty assets, increased revenue diversification, potential integration risks, increased debt/share count for funding.
  • 2026-07-14EventDirect acquisition of royalty streams and intellectual property, impacting future revenue and cost structures. Integration risks and potential synergies.
  • 2026-07-14EventAcquisition of XOMA Royalty Corporation is expected to be accretive to earnings and diversify revenue streams.
  • 2026-06-26EventFinancing structure, debt obligations, potential equity dilution, and capital availability for strategic initiatives.
  • 2026-06-23EventFinancing structure, potential for future equity dilution, and interest expense savings.
  • 2026-06-22EventReduced share count, potentially boosting EPS and signaling management confidence. The repurchase is concurrent with a convertible note offering, suggesting a strategic capital structure adjustment.
  • 2026-06-22EventFinancing structure, share count management, and strategic acquisition funding.
  • 2026-06-12EventMerger completion and integration. The redemption of XOMA's preferred stock simplifies the capital structure of the acquired entity, making the integration process potentially smoother and reducing future financial obligations for the combined company.

Continuous coverage for LGND with alerts, structural playbooks, and options routing lives in the platform. Start a trial →